Combination Therapy With Elimination Diet and Corticosteroids Is Effective for Adults With Eosinophilic Esophagitis

Authors:

Abstract
No abstract available
Funding Information
  • GlaxoSmithKline Australia
  • National Institutes of Health (K24 DK100548, R01 DK101856, T32 DK007634, T35 DK007386)
  • Shire
  • AstraZeneca
  • GlaxoSmithKline
  • Regeneron Pharmaceuticals
  • Shire

This publication has 8 references indexed in Scilit: